baber/WOPTO huggingface dataset:
Patent NZ-587211-A (NZ)
Title: Anisotropic innersprings with varied distance between the coils
Inventor: BEAMON JAMES A
IPC: A47C23/04
Filed: 2009-02-02
Abstract: An anisotropic innerspring 10 with different numbers of coils in different regions of the innerspring 10, comprises a plurality of interconnected coils arranged with axes of the coils parallel and ends of the coils located in common respective planes, the innerspring 10 having multiple regions defined by groups of coils with axes of the coils spaced apart at a common distance, including a first region with coil axes spaced at a first distance and a second region with coil axes spaced at a second distance which is greater than the first distance. The coils of the multiple regions of the innerspring 10 are interconnected by lacing wires which extend between the coils and from one region of the innerspring 10 to another region of the innerspring 10, and the rows of the coils of the innerspring 10 are spaced apart at a constant distance in all regions of the innerspring 10.
Patent NZ-589188-A (NZ)
Title: Stabilized compositions of volatile alkylating agents and methods of using thereof
Inventor: CROOKS PETER
IPC: A01N3/00
Filed: 2006-03-14
Abstract: Disclosed is a topical composition comprising: (a) an active pharmaceutical ingredient consisting of bis(2-chloroethyl)methylamine or a pharmaceutically acceptable salt thereof; and (b) butylated hydroxytoluene. The composition is used to treat skin disorders such as psoriasis, eczema, actinic keratosis, lupus, sarcoidosis, alopecia, cutaneous T-Cell lymphoma, mycosis fungoides, lymphoreticular neoplasia, pleural and peritoneal effusions, cutaneous Bcell lymphoma, pseudolymphomas of the skin, squamous cell carcinoma, basal cell carcinoma, bronchogenic carcinoma, malignant melanoma, lymphosarcoma, chronic lymphocytic leukemia, polycythemia vera, lymphomatoid papulosis and Mucha-Habberman's disease (PLEVA).
Patent NZ-591651-A (NZ)
Title: High titer antibody production and culture media comprising glucose, soy or wheat hydrolsyate, amino acids, and other chemical compounds
Inventor: KRISHNAN RAJESH
IPC: C07K16/28
Filed: 2009-09-24
Abstract: Disclosed is a method for producing a protein comprising inoculating an initial mammalian cell growth medium with host cells expressing the protein and adding supplements comprising: Glucose; L-glutamine; Soy hydrolysate or wheat hydrolysate or both; Adenine sulfate; Adenosine; ammonium vanadate; Biotin; Choline Chloride; Cobalt chloride; Cupric sulfate; Cytidine; D-Calcium Pantothenate; Ethanolamine HCI; Flavin Adenine Dinucleotide; Folic Acid; Glycine; Guanosine; Hypoxanthine; i-inositol; L-alanine; L-arginine; L-asparagine; L-aspartic acid; L-citrulline; L -cysteine-HCI; L-cystine; L-glutamic acid; L-histidine; Lipoic Acid; L -isoleucine; L-Ieucine; L-Iysine; L -methionine; L-ornithine-HCI; L-phenylalanine; L-proline; L-serine; L-threonine; L-tryptophan; L-tyrosine; L-valine; Manganese chloride Tetrahydrate; Niacin; Nickel dichloride hexahydrate; Progesterone; Putrescine 2HCI; Pyridoxine HCI; Riboflavin; Sodium molybdate dehydrate; Sodium phosphate monobasic; Sodium selenite; Thiamine HCI; Thymidine; Tin chloride dehydrate; Uridine; Vitamin B12; Vitamin E; and Zinc sulfate; to the medium. Further disclosed is an aqueous liquid cell culture medium comprising: about 10 g/Iiter soy hydrolysate, about 1.5 g/liter glucose, about 150 mg/liter L-glutamine, pH of about 6.8, HEPES, Sodium bicarbonate buffers, Inorganic salts, Non-essential amino acids, Recombinant human insulin, Trace elements, Surfactants, an amino acid feed wherein the concentration of the components added by said amino acid feed are approximately those set forth below: L-arginine: 126.4 mg/liter L-cystine: 34 mg/liter L-histidine: 42 mg/liter L-isoleucine: 52 mg/liter L-Ieucine: 52 mg/liter L-Iysine: 72 mg/liter L-Methionine: 15.2 mg/liter L-phenylalanine: 33 mg/liter L-threonine: 47.6 mg/liter L -tryptophan: 10.2 mg/liter L-tyrosine: 36 mg/liter L-valine: 46.8 mg/liter L-alanine: 8.9 mg/liter L -asparagine: 30 mg/liter L-aspartic acid: 26.6 mg/liter L-glutamic acid: 29.4 mg/liter Glycine: 15 mg/liter L-proline: 23 mg/liter L-serine: 21 mg/liter wherein the medium does not comprise antibiotics, antimycotics or animal-derived components.
Patent NZ-594632-A (NZ)
Title: Process for foil ripening of cheese
Inventor: HOOFT CORSTIAAN JOHANNES
IPC: A23C19/097
Filed: 2010-02-16
Abstract: 594632 Disclosed herein is a process for preparing foil-ripened cheese comprising (i) introducing brined cheese into a cheese-ripening packaging containing an opening for receiving cheese, (ii) closing the packaging, and (iii) ripening the cheese, characterized in that the cheese-ripening packaging comprises a thermoplastic film coated with an antimicrobial composition comprising a binding agent and at least one antimicrobial compound, whereby (a) said binding agent swells, softens or dissolves in the water that is released from the cheese during its ripening, (b) the antimicrobial composition becomes part of the water phase that, due to ripening, becomes present between the outer cheese surface and the packaging, (c) the antimicrobial compound is able to migrate in the water phase and (d) antimicrobial compound is transferred to the outer cheese surface, and wherein the thermoplastic film has a water vapour transmission rate of at least 10 g/m2/24 hours at 10ºC and 85% relative humidity.
Patent NZ-598831-A (NZ)
Title: Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
Inventor: GAIDUL KONSTANTIN VALENTINOVICH
IPC: A61K9/51
Filed: 2011-05-11
Abstract: 598831 Disclosed herein is an antimicrobial pharmaceutical composition comprising a betalactam antibiotic and a finely dispersed nanostructured silica dioxide, wherein the composition is formulated for parenteral administration, and wherein the betalactam antibiotic and the finely dispersed nanostructured silica dioxide are present in the composition in a weight ratio of 10:1 to 75:1.
Patent NZ-598983-A (NZ)
Title: Storing, displaying and transmitting status information regarding intelligent electronic devices and receiving additional information from a central server
Inventor: BOWE DAVID W
IPC: G06F11/00
Filed: 2010-08-10
Abstract: 598983 Disclosed is a monitoring apparatus. The apparatus includes a communication device to receive data from a plurality of intelligent electronic devices (122), a processor coupled to the communication device and a storage device in communication with the processor which stores instructions adapted to be executed by the processor. For each intelligent electronic device (122), status information is stored based on the received data. The status information for the plurality of the intelligent electronic devices (122) is displayed on a graphical user interface transferred to a remote central server (150) via a communication network. Addition information is received from the central server (150) in connection with at least one of the intelligent electronic devices (122). The additional information includes at least one of a document, a service bulletin, a product advisory, or a recommendation associated with an expected lifespan of the intelligent electronic device (122).
Patent NZ-600189-A (NZ)
Title: Novel 7beta-hydroxysteroid dehydrogenases and their use
Inventor: LIU LUO
IPC: C12P33/06
Filed: 2010-11-30
Abstract: NZ 600189 Disclosed is a 7ß-HSDH comprising an amino acid sequence according to SEQ ID No: 2, as disclosed in the specification, or a sequence derived therefrom with an identity degree of at least 80% to this sequence, with a molecular weight, determined by gel filtration, of about 53 to 60 kDa, and which at least catalyses the stereospecific reduction of a 7-ketosteroid to the corresponding 7ßhydroxysteroid. Also disclosed is a method for the production of ursodesoxycholic acid (UDCA) of the formula (1) as disclosed in the specification.
Patent NZ-609725-A (NZ)
Title: Heating element, humidifier for respiratory apparatus including heating element and respiratory apparatus
Inventor: KLASEK PAUL JAN
IPC: H05B3/58
Filed: 2008-06-30
Abstract: Disclosed is a flexible tube (12) for use in delivering a flow of breathable gas to a patient interface. The tube (12) comprises a heating element with a circuit (6) comprising electrically conductive ink provided on an inner surface and/or an outer surface of the tube (12). The heating element is configured to heat the flow of breathable gas.
Patent NZ-612577-A (NZ)
Title: Patient ventilation device and components thereof
Inventor: NICKOL JOHANNES
IPC: F16J15/12
Filed: 2010-10-29
Abstract: Disclosed is an inlet manifold member for a centrifugal fan in a CPAP breathing or ventilation device with two concentric outlets for better mixing of breathing gases. The inlet member includes a first inlet for receiving a first fluid flow of air and a second inlet for receiving a second fluid flow of oxygen, the inlet member defining a first fluid flow path for the first fluid flow and a second fluid flow path for the second fluid flow, and comprising a first and second outlet, for respectively the first and second paths, the first outlet being of a ring like shape, the second outlet being arranged coaxially to the first inlet and/or being surrounded by the generally ring shaped first outlet. A housing has at least one inlet housing part being provided with the first fluid flow path outlet and the second fluid flow path outlet. A filter element extends over the whole cross section of the first fluid flow path.
Patent NZ-618238-A (NZ)
Title: Irrigation system
Inventor: WILLIAMS ANDREW NEVILLE
IPC: B05B3/04
Filed: 2012-11-29
Abstract: Disclosed is a travelling irrigator including a frame, a primary fluid distribution outlet in the form of a rotating boom configured to rotate around an axis, a secondary fluid distribution outlet. The boom includes an arm which extends from the frame, the arm has a nozzle at one end and a connection to a drive mechanism at the other end. The secondary fluid distribution outlet is a sprayer mounted to a fixed shaft. A pressurized fluid source connected to the boom and sprayer. The travelling irrigator includes a gland sealing spindle that allows the boom to rotate while the sprayer remains static. The travelling irrigator is configured such that in use the sprayer distributes fluid supplied by the pressurised fluid source to a further distance from the axis than fluid is distributed from the boom.
Patent NZ-622403-A (NZ)
Title: Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method
Inventor: SIRANITA AKIO
IPC: G01N33/50
Filed: 2010-11-26
Abstract: Disclosed herein is a method for screening a drug which is efficacious in treating dry eye with a dry eye severity level 3 or higher that is defined in 2007 report of the International Dry Eye Workshop and/or keratoconjunctival disorders, and the use of compounds identified by the method. The method comprises preparing a rabbit model of corneal and conjunctival lesion having corneal and conjunctival epithelial abrasion by instilling n-heptanol solution optionally including ethanol to an eye of a rabbit; and administering a test agent to the eye of the rabbit model and determining an effect of restoring corneal tissue of the test agent, wherein the conditions of cornea and conjuctiva are observed with a dye such as fluorescein. In one embodiment, the compound identified by the method is human serum albumin.
Patent NZ-626719-A (NZ)
Title: Improvements in the removal of animal pelts
Inventor: NICO VOS
IPC: A22B5/08
Filed: 2013-07-22
Abstract: Apparatus is disclosed for removing animal pelts with pair of parallel arms having driven rotatable clamps at ends and an actuator to move arms together or apart at other end of arms.
Patent NZ-704771-A (NZ)
Title: Anti-pcsk9 antibodies with ph-dependent binding characteristics
Inventor: MURPHY ANDREW J
IPC: C07K16/40
Filed: 2013-08-12
Abstract: The present invention provides antibodies and antigen-binding fragments thereof that specifically bind proprotein convertase subtilisin/kexin-9 (PCSK9) with greater affinity at neutral pH than at acidic pH. The antibodies of the invention may possess one or more amino acid changes as compared to antibodies that do not exhibit pH-dependent binding properties. For example, the present invention includes anti-PCSK9 antibodies which possess one or more histidine substitutions in one or more complementarity determining regions. The antibodies of the invention, with pH-dependent binding properties, remain in circulation and exhibit cholesterol lowering activity for prolonged periods of time in animal subjects as compared to anti-PCSK9 antibodies that do not exhibit pH-dependent binding properties. The antibodies of the invention are therefore useful for treating diseases and disorders related to elevated LDL-C levels, wherein the antibodies of the invention can be administered to a patient at a lower dose and/or with less frequent dosing as compared to antibodies that do not exhibit pH-dependent binding properties.
Patent NZ-716064-A (NZ)
Title: Multispecific antibodies, multispecific activatable antibodies and methods of using the same
Inventor: LOWMAN HENRY BERNARD
IPC: C07K16/28
Filed: 2014-07-25
Abstract: This invention relates to a multispecific activatable antibody that in an activated state binds two or more targets or two or more epitopes or a combination thereof, the multispecific activatable antibody comprising: at least an antibody (AB1) that specifically binds a first target or epitope, wherein AB1 comprises an IgG antibody comprising a heavy chain and a light chain; at least an scFv (AB2) that specifically binds a second target or epitope, wherein an AB2 is fused to the amino terminus of each heavy chain of AB1; at least a first masking moiety (MM1) coupled to the AB1 that inhibits the binding of the AB1 to its target when the multispecific activatable antibody is in an uncleaved state; at least a first cleavable moiety (CM1) coupled to the AB1, wherein the CM1 is a polypeptide that functions as a substrate for a first protease, and wherein at least a portion of the multispecific activatable antibody in an uncleaved state has a structural arrangement from N-terminus to C-terminus as follows: MM1-CM1-AB1; at least a second masking moiety (MM2) coupled to the AB2 that inhibits the binding of the AB2 to its target when the multispecific activatable antibody is in an uncleaved state; and at least a second cleavable moiety (CM2) coupled to the AB2, wherein the CM2 is a polypeptide that functions as a substrate for a second protease, and wherein at least a portion of the multispecific activatable antibody in an uncleaved state has a structural arrangement from N-terminus to C-terminus as follows: MM2-CM2-AB2. The invention enables targeting of multiple targets and/or multiple epitopes with a single molecule and also provides for increased selectivity for the intended targets and for a reduction of adverse effects upon administration.
Patent NZ-720964-A (NZ)
Title: A pyrolysis chamber for treating domestic refuse and dwelling equipped with such a chamber
Inventor: SPENCER NIK
IPC: C10B47/04
Filed: 2015-01-09
Abstract: Existing approaches to refuse handling are all based on historical approaches which rely on a network of refuse collection vehicles collecting waste from individual households and delivering this to a centralised landfill or MBI location. This is highly undesirable and wasteful. An alternative process is disclosed, relying on the thermal treatment of waste and like products produced or brought in to the residential property and processed within the domestic curtilage to produce fuel or other forms of energy. Thus, domestic waste will be thermally treated at the home instead of being collected by local authorities and disposed of. The waste input material will be loaded into a domestically engineered thermal conversion unit either directly or after a pre-process such as shredding. The feedstock will be converted into fuels by a thermal treatment, such as pyrolysis. The resultant output of oil and gas can either be stored or fed into a boiler unit to be used as a fuel to produce hot water, or used to run an electricity generating unit to power the dwelling in question or for supply to a feed-in tariff. Thus, a domestic dwelling includes a thermal treatment unit for processing waste produced in the dwelling, an output of the thermal treatment unit being combusted for producing an energy output for the dwelling. The suitable pyrolysis chamber disclosed has a receptacle for the refuse, the receptacle being defined by a double-skinned enclosure having an exterior wall, an interior heat-conductive wall, and a sealed void between the two walls in which a working fluid is disposed, and at least one heating element in thermal contact with the enclosure.
Patent NZ-721332-A (NZ)
Title: Fgf-18 formulation in xyloglucan gels
Inventor: LO PRESTI CATERINA
IPC: A61K9/00
Filed: 2014-12-23
Abstract: The invention relates to the field of pharmaceutical formulations. More particularly it is directed to xyloglucan hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compound and to methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
Patent NZ-722774-A (NZ)
Title: Network-controlled charging system for electric vehicles
Inventor: LOWENTHAL RICHARD
IPC: G07F17/24
Filed: 2009-01-07
Abstract: A charge transfer device (110) for transferring charge between a power source and electric vehicles, comprises a control device to turn electric supply on and off to enable and disable charge transfer for electric vehicles; a transceiver to communicate requests for charge transfer with a remote server and receive communications from the remote server via a data control unit (130) that is connected to the remote server (140) through a wide area network; and a controller, coupled with the control device and the transceiver, to cause the control device to turn the electric supply on based on communication from the remote server. The controller is further to manage charge transfer based on power grid load data received from the remote server. A network-controlled charge transfer system for electric vehicles, comprises a server and a data control unit connected to a wide area network for access to the server (140); and the above described charge transfer device, remote from the server and the data control unit (130).
Patent NZ-723940-A (NZ)
Title: Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
Inventor: JANDELEIT BERND
IPC: C07F9/48
Filed: 2015-02-03
Abstract: β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.
Patent NZ-736200-A (NZ)
Title: Specific detection of clusterin isoforms
Inventor: YERRAMILLI MURTHY
IPC: G01N33/68
Filed: 2016-04-29
Abstract: The invention provides methods and compositions for the detection of specific isoforms of clusterin.
Patent NZ-736802-A (NZ)
Title: Agricultural composition
Inventor: HURST MARK ROBIN HOLMES
IPC: A01N25/12
Filed: 2016-04-13
Abstract: A granular composition that comprises one or more microorganisms, two or more plant powders and a biodegradable water-absorbent agent. Also provided is a method of producing a granular composition by admixing a composition comprising two or more plant powders and a biodegradable water-absorbent agent, and (i) one or more lubricants to form a dough, and processing the dough to form granules, or (ii) coating a substrate with the dough to form the granular composition. The microorganism can be located in the admixture, the dough or both the admixture and the dough. The granular composition is applied to soil to, for example, kill or control pests, maintain or increase plant or crop growth, maintain or increase pasture production, maintain or increase plant, crop or pasture yield, deliver probiotics to grazing animals or livestock, and/or bioremediate the soil.
Patent PT-107927-A (PT)
Title: Processo de produção de derivados de sacáridos e respetivos catalisadores adequados
Inventor: LUÍS JORGE ABREU CHORÃO DE QUELHAS DUARTE
IPC: C13K13/00
Filed: 2014-09-29
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UM NOVO PROCESSO PARA A CATÁLISE EFICIENTE DE REAÇÕES ENVOLVENDO COMPOSTOS QUÍMICOS PRESENTES OU DERIVADOS DE MATERIAL VEGETAL, E A UM NOVO CATALISADOR PREPARADO A PARTIR DAS ARGILAS DA ILHA DE PORTO SANTO DE ACORDO COM O PROCESSO AQUI DESCRITO. AO CONTRÁRIO DOS CATALISADORES CORRENTEMENTE UTILIZADOS NA INDÚSTRIA E DESCRITOS NA LITERATURA PARA ESTAS REAÇÕES, POR EXEMPLO CATALISADORES HOMOGÉNEOS COMO ÁCIDO SULFÚRICO OU ÁCIDO CLORÍDRICO, A INVENÇÃO AQUI DESCRITA UTILIZA CATALISADORES HETEROGÉNEOS QUE APRESENTAM UMA APLICAÇÃO MAIS SIMPLES, ASSOCIADA A UMA MAIS FÁCIL RECUPERAÇÃO E REUTILIZAÇÃO APÓS AS REAÇÕES. A UTILIZAÇÃO DESTE TIPO DE CATALISADORES E REAÇÕES É DE PARTICULAR IMPORTÂNCIA PARA A ÁREA DAS BLORREFINARLAS E DA VALORIZAÇÃO DA BLOMASSA VEGETAL.
Patent PT-116178-A (PT)
Title: Almofada anti-rugas, ergonómica e ajustável
Inventor: ANA SOFIA RAMOS PEREIRA WILLINER
IPC: A47G9/10
Filed: 2020-03-20
Abstract: O OBJETO DA PRESENTE INVENÇÃO REFERE SE A UMA ALMOFADA CRIADA COM O OBJETIVO DE AJUDAR O UTILIZADOR A DORMIR MELHOR, ESPECIALMENTE EM CASOS DE TRATAMENTOS ANTIRRUGAS E ANTI VINCOS DURANTE O SONO, USO DE SISTEMAS PCVA (PRESSÃO POSITIVA CONTÍNUA NAS VIAS AÉR EAS), RECUPERAÇÃO PÓS CIRÚRGICA OU FERIDAS NA CABEÇA, ERGONOMIA CERVICAL PARA MELHOR APOIO DA CABEÇA E PESCOÇO, TRATAMENTOS ESPECÍFICOS PARA MELHOR ABSORÇÃO DE CREMES DURANTE A NOITE, PERMITINDO DORMIR DE CABEÇA PARA BAIXO. A ALMOFADA DA PRESENTE INVENÇÃO TEM UM FORMATO ÚNICO, RETA NO CONTACTO COM O COLCHÃO E ARREDONDADA EM CIMA, NO CONTACTO COM O ROSTO, SENDO COMPOSTA POR 3 ZONAS: A ZONA CENTRAL (2,6) PARA APOIAR O CRÂNIO QUANDO VIRADO PARA CIMA, E AS DUAS ZONAS LATERAIS DESENHADAS EM FORMATO DE LETRA ¿C¿ (1,2,3), PARA DORMIR PARA OS LADOS.
Patent RU-94021100-A (RU)
Inventor: GORSHKOV V N
IPC: H03K3/53
Filed: 1994-06-06
Abstract: FIELD: pulse devices. SUBSTANCE: device has power supply, switching transistors, diodes, accumulating capacitor and load. Resistors, capacitors, transistors and diodes are introduced to accomplish the goal of invention. Introduced elements and their connections provide implementation of high- voltage pulse modulator in solid-state element base. This results in possibility to decrease weight and size along with increased reliability and elimination of additional circuits, training and testing during long-term storage. EFFECT: decreased weight and size, increased reliability.
Patent RU-94025175-A (RU)
Inventor: OSOKIN V S
IPC: H04N9/64
Filed: 1994-07-04
Abstract: FIELD: television; TV systems SECAM. SUBSTANCE: adaptive color-definition corrector implementing method of differential aperture correction is provided with units affording quasi-regeneration of saturated color transform bursts by interpolation of transient characteristics of through chrominance path and adapting to saturation of color transfers. EFFECT: improved color definition without signal-to-noise ratio.